These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9857272)

  • 21. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of simvastatin treatment in patients with combined hyperlipidemia in clinical practice. For the Simvastatin Combined Hyperlipidemia Registry Group.
    Vicari RM; Wan GJ; Aura AM; Alexander CM; Markson LE; Teutsch SM
    Arch Fam Med; 2000; 9(9):898-905. PubMed ID: 11031398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modification of the lipid profile in coronary patients undergoing cardiac rehabilitation].
    Brízida L; Mendes M; Adegas A; Seabra-Gomes R
    Rev Port Cardiol; 1996 Dec; 15(12):877-83, 863-4. PubMed ID: 9052963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in cardiac rehabilitation.
    O'Farrell P; Murray J; Huston P; LeGrand C; Adamo K
    Can J Cardiol; 2000 Mar; 16(3):319-25. PubMed ID: 10744794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal.
    McKenney JM
    Pharmacotherapy; 2003 Sep; 23(9 Pt 2):26S-33S. PubMed ID: 14524636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefits of cardiac rehabilitation and exercise training in secondary coronary prevention in the elderly.
    Lavie CJ; Milani RV; Littman AB
    J Am Coll Cardiol; 1993 Sep; 22(3):678-83. PubMed ID: 8354798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
    Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
    Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of cardiovascular events in patients at optimal values for combined lipid parameters.
    Stanek EJ; Sarawate C; Willey VJ; Charland SL; Cziraky MJ
    Curr Med Res Opin; 2007 Mar; 23(3):553-63. PubMed ID: 17357251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
    Borgia MC; Medici F
    Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the management of dyslipidemia.
    Irons BK; Snella KA; McCall K; MacLaughlin EJ; Villarreal M
    Am J Health Syst Pharm; 2002 Sep; 59(17):1615-25. PubMed ID: 12224342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease.
    Lavie CJ; Milani RV
    Am J Cardiol; 1994 Dec; 74(12):1192-5. PubMed ID: 7977088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nurse-led cardiac rehabilitation programme improves health behaviours and cardiac physiological risk parameters: evidence from Chengdu, China.
    Jiang X; Sit JW; Wong TK
    J Clin Nurs; 2007 Oct; 16(10):1886-97. PubMed ID: 17880478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid disorders: justification of methods and goals of treatment.
    Braunstein JB; Cheng A; Cohn G; Aggarwal M; Nass CM; Blumenthal RS
    Chest; 2001 Sep; 120(3):979-88. PubMed ID: 11555537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.